Fang Chenyan, Zhu Zhoujun, Cao Jun, Huang Jun, Xu Yipeng
Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China.
Department of Gynecology, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, 10117, Berlin, Germany.
Orphanet J Rare Dis. 2025 Jul 30;20(1):389. doi: 10.1186/s13023-025-03896-w.
Fanconi anemia (FA) is a rare genetic disorder caused by defects in the repair of DNA interstrand crosslinks (ICLs)-highly toxic lesions that impede essential processes like DNA replication and transcription, leading to severe genome instability. Clinically, FA presents with a broad spectrum of symptoms, including progressive bone marrow failure, congenital abnormalities, and an elevated predisposition to various malignancies, particularly acute myeloid leukemia and squamous cell carcinomas. This review provides a comprehensive overview of both the endogenous and exogenous sources of ICLs and the DNA repair pathways responsible for their resolution, with a primary focus on the FA pathway. We also discuss the tumorigenic consequences of FA pathway deficiencies, highlighting the molecular mechanisms that contribute to the heightened cancer risk observed in FA patients.
范可尼贫血(FA)是一种罕见的遗传性疾病,由DNA双链交联(ICL)修复缺陷引起,ICL是一种剧毒损伤,会阻碍DNA复制和转录等基本过程,导致严重的基因组不稳定。临床上,FA表现出广泛的症状,包括进行性骨髓衰竭、先天性异常以及对各种恶性肿瘤,特别是急性髓系白血病和鳞状细胞癌的易感性增加。本综述全面概述了ICL的内源性和外源性来源以及负责解决这些问题的DNA修复途径,主要关注FA途径。我们还讨论了FA途径缺陷的致瘤后果,强调了导致FA患者癌症风险增加的分子机制。